槲皮素-3-O-乙酸苯佐卡因的合成及抗肿瘤活性研究
发布时间:2018-10-24 18:20
【摘要】:目的:合成槲皮素-3-O-乙酸苯佐卡因,并测定其抗肿瘤活性。方法:以芦丁为原料,利用苄基选择性保护羟基,脱去芦丁糖,再经Williamson反应及脱苄基,合成了槲皮素-3-O-乙酸苯佐卡因。结果:收率72.5%。经1H NMR、13C NMR及MS显示,与目标化合物相吻合。用MTT法检测目标化合物对肿瘤细胞增殖的抑制作用,结果显示:目标化合物对EC109的抑制作用(IC50=10.25μmol/L)明显优于母药槲皮素(IC50=31.884μmol/L),和5-FU(IC50=41.738μmol/L);其对EC9706及B16-F10两种肿瘤细胞的抑制作用也均强于母药槲皮素。结论:槲皮素-3-O-乙酸苯佐卡因较槲皮素和5-FU具有更强的细胞增殖抑制活性。
[Abstract]:Aim: to synthesize quercetin-3-o-acetic acid benzocaine and to determine its anti-tumor activity. Methods: using rutin as raw material, benzyl selective protection of hydroxyl group, removal of rutin sugar, Williamson reaction and debenzyl group were used to synthesize quercetin 3-Oacetate benzocaine. Results: the yield was 72.5%. The results of 1H NMR,13C NMR and MS show that it is consistent with the target compound. The inhibitory effects of the target compounds on the proliferation of tumor cells were detected by MTT assay. The results showed that the inhibitory effect of the target compound on EC109 (IC50=10.25 渭 mol/L) was significantly superior to that of IC50=31.884 渭 mol/L and 5-FU (IC50=41.738 渭 mol/L), and the inhibitory effect of the target compound on EC9706 and B16-F10 tumor cells was also stronger than that of quercetin. Conclusion: quercetin-3-o-acetic acid benzocaine has stronger cell proliferation inhibitory activity than quercetin and 5-FU.
【作者单位】: 郑州工业应用技术学院医学院;郑州工业应用技术学院药学院;郑州大学药学院;
【基金】:基金资助:郑州地方高校技术技能名师工作室(No.郑教高[2015]70号])~~
【分类号】:R914;R96
本文编号:2292178
[Abstract]:Aim: to synthesize quercetin-3-o-acetic acid benzocaine and to determine its anti-tumor activity. Methods: using rutin as raw material, benzyl selective protection of hydroxyl group, removal of rutin sugar, Williamson reaction and debenzyl group were used to synthesize quercetin 3-Oacetate benzocaine. Results: the yield was 72.5%. The results of 1H NMR,13C NMR and MS show that it is consistent with the target compound. The inhibitory effects of the target compounds on the proliferation of tumor cells were detected by MTT assay. The results showed that the inhibitory effect of the target compound on EC109 (IC50=10.25 渭 mol/L) was significantly superior to that of IC50=31.884 渭 mol/L and 5-FU (IC50=41.738 渭 mol/L), and the inhibitory effect of the target compound on EC9706 and B16-F10 tumor cells was also stronger than that of quercetin. Conclusion: quercetin-3-o-acetic acid benzocaine has stronger cell proliferation inhibitory activity than quercetin and 5-FU.
【作者单位】: 郑州工业应用技术学院医学院;郑州工业应用技术学院药学院;郑州大学药学院;
【基金】:基金资助:郑州地方高校技术技能名师工作室(No.郑教高[2015]70号])~~
【分类号】:R914;R96
【相似文献】
相关期刊论文 前10条
1 赵丽敏;;实验室中苯佐卡因的制备[J];齐齐哈尔医学院学报;2009年10期
2 杨福才;;介绍一种止痒药水苯佐卡因溶液[J];中国药学杂志;1984年06期
3 倪宏;;开发苯佐卡因新剂型[J];现代应用药学;1987年06期
4 卢忠;苯佐卡因的制备方法[J];数理医药学杂志;2000年05期
5 王瑞,张淼;紫外分光光度法测定苯佐卡因软膏中苯佐卡因的含量[J];第一军医大学分校学报;2005年01期
6 ;警惕苯佐卡因引起的高铁血红蛋白血症[J];中国社区医师;2011年30期
7 韦宝伟;刘布鸣;陈力力;刘元;姚树汉;;复方苯佐卡因凝胶对试验性牙痛模型的影响[J];国际口腔医学杂志;2011年06期
8 杨丽杰;牟阳;王金华;胡宝荣;张婧;;高效液相色谱法测定苯佐卡因软膏中苯佐卡因含量[J];中国药业;2012年15期
9 王体强,宋念蓉;比色法测定苯佐卡因及其软膏制剂的含量[J];重庆医科大学学报;1990年04期
10 ;苯佐卡因:潜在致命的罕见不良反应[J];中国食品药品监管;2011年05期
相关重要报纸文章 前2条
1 监新;苯佐卡因可引起高铁血红蛋白血症[N];中国医药报;2011年
2 本报记者陈铮 整理;FDA警告苯佐卡因 口腔止痛凝胶和溶液严重不良反应[N];中国医药报;2011年
,本文编号:2292178
本文链接:https://www.wllwen.com/yixuelunwen/yiyaoxuelunwen/2292178.html
最近更新
教材专著